Violet Therapeutics is a pre-clinical stage company leveraging first-in-class platforms to identify, map, and mine the cellular connectome. Violet’s drug discovery programs are focused on CNS diseases enabled by the novel targets elucidated by their platforms. Violet was co-founded by Mass General Brigham Ventures and scientists from Brigham &